These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2522312)

  • 1. Vitiligo following diphencyprone dermatitis.
    MacDonald-Hull SP; Cotterill JA; Norris JF
    Br J Dermatol; 1989 Feb; 120(2):323. PubMed ID: 2522312
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitiligo complicating diphencyprone sensitization therapy for alopecia universalis.
    Henderson CA; Ilchyshyn A
    Br J Dermatol; 1995 Sep; 133(3):496-7. PubMed ID: 8547018
    [No Abstract]   [Full Text] [Related]  

  • 3. Vitiligo as a reaction to topical treatment with diphencyprone.
    Hatzis J; Gourgiotou K; Tosca A; Varelzidis A; Stratigos J
    Dermatologica; 1988; 177(3):146-8. PubMed ID: 3169339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urticaria as a side-effect of diphencyprone therapy for resistant viral warts.
    Short KA; Higgins EM
    Br J Dermatol; 2005 Mar; 152(3):583-5. PubMed ID: 15787842
    [No Abstract]   [Full Text] [Related]  

  • 5. Vitiligo as an adverse reaction to topical diphencyprone.
    Pan JY; Theng C; Lee J; Goh BK
    Ann Acad Med Singap; 2009 Mar; 38(3):276-7. PubMed ID: 19347085
    [No Abstract]   [Full Text] [Related]  

  • 6. Persistent vitiligo induced by diphencyprone.
    Duhra P; Foulds IS
    Br J Dermatol; 1990 Sep; 123(3):415-6. PubMed ID: 2206982
    [No Abstract]   [Full Text] [Related]  

  • 7. Narrow-band ultraviolet B treatment for diphenylcyclopropenone-induced vitiliginous lesions.
    Oh YJ; Shin MK; Lee MH
    Acta Derm Venereol; 2012 Jan; 92(1):102-3. PubMed ID: 22215015
    [No Abstract]   [Full Text] [Related]  

  • 8. Prospective study of urticaria after diphencyprone therapy in patients with viral warts.
    Choi JE; Seo SH; Kim IH; Son SW
    Int J Dermatol; 2007 Dec; 46(12):1313-4. PubMed ID: 18173535
    [No Abstract]   [Full Text] [Related]  

  • 9. Generalized urticaria with use of diphencyprone in the treatment of warts.
    Culp BL; Wells MJ
    J Drugs Dermatol; 2007 May; 6(5):529-30. PubMed ID: 17679188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recall dermatitis at patch test sites in alopecia areata treated with diphencyprone.
    Nuara A; Cruz PD
    Dermatitis; 2012; 23(2):98-9. PubMed ID: 22653133
    [No Abstract]   [Full Text] [Related]  

  • 11. Vitiligo and topical allergens.
    Orecchia G; Perfetti L
    Dermatologica; 1989; 179(3):137-8. PubMed ID: 2591620
    [No Abstract]   [Full Text] [Related]  

  • 12. Provoking factors, including chemicals, in Dutch patients with vitiligo.
    Vrijman C; Hosseinpour D; Bakker JG; Wolkerstorfer A; Bos JD; van der Veen JP; Luiten RM
    Br J Dermatol; 2013 May; 168(5):1003-11. PubMed ID: 23252956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hazards in the use of diphencyprone.
    Shah M; Lewis FM; Messenger AG
    Br J Dermatol; 1996 Jun; 134(6):1153. PubMed ID: 8763448
    [No Abstract]   [Full Text] [Related]  

  • 14. Dermatitis produced by applications of monobenzone in patients with active vitiligo.
    Nordlund JJ; Forget B; Kirkwood J; Lerner AB
    Arch Dermatol; 1985 Sep; 121(9):1141-4. PubMed ID: 2931053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diphencyprone in the treatment of alopecia areata.
    Happle R; Hausen BM; Wiesner-Menzel L
    Acta Derm Venereol; 1983; 63(1):49-52. PubMed ID: 6191489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of alopecia areata with diphenylcyclopropenone].
    Kietzmann H; Hardung H; Christophers E
    Hautarzt; 1985 Jun; 36(6):331-5. PubMed ID: 3160683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergic contact dermatitis from dyes in wigs following diphencyprone treatment.
    Crichlow S; Warin AP
    Contact Dermatitis; 2004 Sep; 51(3):148-9. PubMed ID: 15479204
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cutaneous side effects of clinically relevant cytokine therapies].
    Trefzer U; Hofmann M; Sterry W
    Dtsch Med Wochenschr; 2003 Aug; 128(34-35):1782-7. PubMed ID: 12934174
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pellagra-like changes following glibenclamide treatment in a patient with diabetes mellitus and vitiligo].
    Berova N; Lazarova A
    Dermatol Monatsschr; 1988; 174(1):50-1. PubMed ID: 2965658
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dermal changes in response to hormonal contraceptives (author's transl)].
    Scholz C; Donat H
    Zentralbl Gynakol; 1981; 103(19):1158-64. PubMed ID: 6458978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.